UAE – Oracle Health, Cleveland Clinic, and UAE-based tech group G42 have partnered to launch a new artificial intelligence (AI)-powered platform aimed at transforming how healthcare is delivered and managed.
Designed to improve clinical care and public health, the platform will use AI to support national data analytics, clinical decision-making, and real-time population health insights.
The new system is described as secure, scalable, and accessible. It will be built using Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health technologies.
These will be combined with Cleveland Clinic’s medical expertise and G42’s strength in sovereign AI infrastructure, data integration, and advanced clinical models.
Initially, the platform will launch in the United States and United Arab Emirates, with plans to expand globally. Once fully implemented, it will serve as a central AI-driven hub for healthcare delivery.
The impact is expected to be significant. The platform will continuously analyze public and population health data, giving healthcare providers up-to-date clinical intelligence at the point of care.
This will help doctors and healthcare systems better understand disease trends, identify risks earlier, and make more informed decisions. At the same time, health systems can better manage resources and reduce costs.
By bridging the gap between research and care, the platform will also make it easier to identify and enroll patients in clinical trials directly at the point of care.
Researchers, in turn, will gain access to valuable real-world data that can speed up the development of new treatments and therapies.
The partners stress that the platform is built around data privacy, clinical quality, and operational efficiency.
“This venture represents a bold leap forward in our collective mission to transform how healthcare is delivered,” said Dr. Tom Mihaljevic, CEO of Cleveland Clinic.
“AI-powered care models can truly reshape global health systems—delivering better outcomes, lower costs, and broader access to care.”
This initiative follows a previous partnership between Cleveland Clinic and G42, announced in April, focused on advancing AI in healthcare.
The two organizations continue to explore how AI can fuel medical innovation and improve operational efficiency.
In the U.S., physicians are gradually becoming more open to the role of AI in healthcare.
According to a 2024 survey by the American Medical Association, 35% of doctors said they are more excited than concerned about AI, an increase from 30% in 2023.
At the same time, the percentage of physicians who are more worried than enthusiastic dropped to 25% in 2024, down from 29% the year before.
Doctors are especially interested in AI’s potential to reduce paperwork, assist with diagnostics, and personalize treatment plans.